EA
AMPH icon

Emerald Acquisition’s Amphastar Pharmaceuticals AMPH Stock Holding History

Emerald Acquisition’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$7.01M Buy
369,759
+169,639
+85% +$3.08M 0.01% 1030
2016
Q2 		$3.23M Buy
+200,120
New +$2.82M 0.01% 1597

Other funds holding AMPH

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Emerald Acquisition's AMPH Position: Q3 2016 in Review

Emerald Acquisition increased its Amphastar Pharmaceuticals (AMPH) stake by 85% in Q3 2016, buying an estimated $3.08M and bringing the position to 369,759 shares worth $7.01M. The position accounts for 0.01% of the portfolio, ranked #1030.

Emerald Acquisition first reported a position in AMPH in Q2 2016 and has held it in 2 quarters since. 134 funds tracked by Wall St. Rank hold AMPH as of Q3 2016.

  • Emerald Acquisition held 369,759 shares of Amphastar Pharmaceuticals worth $7.01M as of Q3 2016.
  • Emerald Acquisition bought 169,639 Amphastar Pharmaceuticals shares in Q3 2016, an estimated $3.08M.
  • Amphastar Pharmaceuticals made up 0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1030 holding.
  • Emerald Acquisition first reported a position in Amphastar Pharmaceuticals in Q2 2016 and has held it in 2 quarters since.
  • 134 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.